Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in

S Vigili de Kreutzenberg1, A Coracina, A Volpi

  • 1Department of Clinical and Experimental Medicine, University of Padova, Via Giustiniani 2, 35128 Padova, Italy. saula.dekreutzenberg@unipd.it

Abstract

Insights

Diabetic retinopathy and nephropathy are linked to carotid atherosclerosis in type 2 diabetes patients. Microvascular complication severity correlates with carotid atherosclerosis severity, suggesting shared pathways.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Ophthalmology

Background:

  • Diabetic complications affect both small (microangiopathy) and large (macroangiopathy) blood vessels.
  • Understanding shared mechanisms between micro- and macrovascular complications is crucial for type 2 diabetes management.

Purpose of the Study:

  • To investigate the association between carotid atherosclerosis and microangiopathy in patients with type 2 diabetes mellitus.
  • To explore common pathogenic mechanisms linking micro- and macrovascular complications.

Main Methods:

  • Cross-sectional study of 662 type 2 diabetes patients.
  • Carotid atherosclerosis assessed via ultrasound (intima-media thickness, plaque presence/type, stenosis).
  • Microangiopathy evaluated through diabetic retinopathy and nephropathy assessment.

Main Results:

  • Carotid plaque presence was associated with older age, male sex, smoking history, longer diabetes duration, lower HDL cholesterol, and more ischemic heart disease.
  • Microangiopathies (retinopathy, nephropathy) were more prevalent in patients with carotid plaque.
  • Retinopathy (alone or with nephropathy) was independently associated with carotid plaque; microangiopathy severity correlated with carotid atherosclerosis severity.

Conclusions:

  • Diabetic retinopathy and nephropathy are independently linked to carotid plaque in type 2 diabetes.
  • Severity of microvascular disease correlates with the extent of carotid atherosclerosis.
  • Findings suggest common underlying pathogenic mechanisms for micro- and macrovascular complications in diabetes.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...